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Abstract
Background: Determining the age-specific hospitalization burden associated with seasonal influenza and the
(H1N1) 2009 pandemic is important for the development of effective vaccine strategies and clinical management.
The aim of this study was to investigate age-specific differences in hospitalization rates during the pandemic and
seasonal periods.
Methods: Using the Taiwan National Health Insurance Research Database (NHIRD), we identified hospitalized
patients with a principle discharge diagnosis of influenza-related infection (ICD-9-CM 487) between 2009 and 2012.
Results: Based on the time distribution of influenza-related hospitalizations and previously reported epidemic
periods, the first and second waves of the (H1N1) 2009 pandemic (p1 is known as 2009.07-2010.01, and p2 is
known as 2010.12-2011.03) and three seasonal periods (s1 is known as 2010.03-2010.11, s2 is known as 2011.10-2012.03,
and s3 is known as 2012.04-2012.10) were found. During these five periods, children younger than 7 years of age
consistently had the highest hospitalization rate of the studied age groups. In individuals younger than 50 years of age,
the seasonal periods were associated with a significantly lower risk of hospitalization than that of p1 (Relative risk
(RR) range = 0.18–0.85); however, they had a significantly higher hospitalization risk for adults over 50 years of age
(RR = 1.51–3.22). Individuals over 50 years of age also had a higher intensive care unit admission rate and case
fatality ratio than individuals under than 50 years of age during the seasonal periods and especially during the
pandemic periods.
Conclusions: In both pandemic and seasonal periods, the highest hospitalization rate was observed for children
younger than 7 years of age. Adults over 50 years of age had a higher hospitalization risk during the seasonal
periods and a higher clinical severity during the pandemic periods. Those results emphasize that the importance
of influenza-related prevention strategies in the younger and older age groups, either seasonal or pandemic
periods.
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Background
Influenza infection causes severe morbidity and mortal-
ity around the world [1]. Although the influenza-
associated disease burden and use of medical facilities
can be reduced by effective vaccination strategies [2], the
influenza virus is characterized by antigenic alterations
that may lower vaccine efficacy [3]. Pandemic influenza
arising from novel subtypes of the virus further increases
disease severity [4]. Therefore, the epidemiological char-
acteristics of pandemic and seasonal influenza periods
can aid in the development of prevention strategies and
clinical management.
Seasonal influenza A (H3N2 and H1N1) and influenza B
have been the three major circulating virus subtypes in
humans for many years [1]. In 2009, a new strain of
influenza A, namely, pandemic A (H1N1) 2009 virus
(A(H1N1)pdm09), spread rapidly to different countries. In
2010–2011, a second wave of the pandemic H1N1 infection
occurred in Hong Kong, the UK, Wisconsin and Taiwan
[5–8]. From 2009 to 2012 in Taiwan, there were five epi-
demic periods. The dominant individual circulating
virus was A(H1N1)pdm09 from July 2009 to January
2010, influenza B and subsequent A(H3N2) from
March 2010 to November 2010, A(H1N1)pdm09 from
December 2010 to March 2011, influenza B from
October 2011 to March 2012 and A(H3N2) from April
2012 to October 2012 [7–9].
Hospitalized patients from the (H1N1) 2009 pandemic
period were younger than patients from the seasonal pe-
riods [10–13]. Moreover, during the (H1N1) 2009 pan-
demic, a high proportion of deaths occurred in individuals
under 60 years of age, whereas during the seasonal pe-
riods, a high proportion of deaths occurred in individuals
65 years and older [14–16]. Not all studies included data
on younger children or information about age distribu-
tions in their analyses of influenza-related hospitalizations
[10, 11]. Comparisons of the hospitalization rate and
the severity of infection during the 2009 pandemic
and seasonal periods have been presented in several
studies [10–17]. However, few studies have compared
the age-specific hospitalization burden associated with
seasonal influenza and pandemic periods [12, 13].
Nationwide population-based data can provide valuable
information on the disease burden and the impact of influ-
enza infection on health. Using the Taiwan National Health
Insurance Research Database (NHIRD), we aimed to evalu-
ate the age-specific hospitalization rates and clinical severity
associated with influenza during the pandemic and during
seasonal periods between 2009 and 2012.
Methods
Data source
Population-based data consisting of pneumonia and in-
fluenza cases from 2002 to 2012 were obtained from the
Taiwan NHIRD. The NHIRD is a claims database that
collects nationwide outpatient/emergency and inpatient
data and has been used extensively in many studies [18].
The National Health Insurance (NHI) program, which
was implemented on March 1, 1995, provides universal
health care for all legal residents and covers over 99 %
(approximately 23 million) of the population in Taiwan.
By using encrypted identification numbers, we retrieved
admission records and linked all information on patient
characteristics and prescriptions from 2009 to 2012. In
each admission record, up to five discharge diagnoses
were available and coded using the International Classifi-
cation of Diseases, Ninth Revision, Clinical Modification
(ICD-9-CM). This study was reviewed and approved by
the Institutional Review Board of the Ditmanson
Medical Foundation of Chia-Yi Christian Hospital,
Taiwan.
Study subjects
In cases of hospitalization, the discharge code ICD-9-CM
487 was more specific for influenza-related infection than
the 480–487 codes (which include pneumonia and influ-
enza). ICD-9-CM code 487 was used in the principle diag-
nosis at discharge, and it was used to identify episodes of
influenza-related hospitalization. Patients who had been
hospitalized because of influenza infection between 2009
and 2012 were included. During the study period, five
epidemic periods were defined according to the influenza-
positive rate from the laboratory confirmation of the
Taiwan Centers for Disease Control (CDC) surveillance
network [7–9]. The epidemic periods occurred from July
2009 to January 2010 (pandemic period, p1), March 2010
to November 2010 (seasonal period 1, s1), December 2010
to March 2011 (the second wave of pandemic, p2),
October 2011 to March 2012 (seasonal period 2, s2) and
April 2012 to October 2012 (seasonal period 3, s3). To
compare the difference in the rates of age-specific
hospitalization and clinical severity between the pandemic
and seasonal periods, we stratified the patients by age for
each of the five study periods. Because Taiwan has imple-
mented a Nationwide In-school Influenza Vaccination
strategy, school-aged children have a much higher vaccin-
ation rate than children under the age of 7. Therefore, the
patients were categorized into five age groups (0–6, 7–12,
13–18, 19–49, 50–64 and ≥ 65 years of age) to investigate
the effect of the Nationwide In-school Influenza Vaccin-
ation strategy.
Statistical analysis
We calculated the age-specific hospitalization rate among
the five epidemics between 2009 and 2012. The numerator
of the hospitalization rate was the number of incident
cases, and the denominator was the population of a spe-
cific age group during that year, which was obtained from
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the Department of Statistics in the Ministry of the Interior
for Executive Yuan in Taiwan. The hospitalization rate of
specific age groups during p1 was used as the reference,
which allowed for a successful comparison of the
hospitalization rate between two pandemic periods. Using
p1 as the reference also allowed an investigation of the
change between the seasonal and pandemic periods by
using the same reference. The relative risk (RR) and 95 %
confidence interval (CI) were used to estimate the
hospitalization rates between periods using Poisson re-
gression. The intensive care unit (ICU) admission rate and
the case fatality ratio (CFR) represented the clinical sever-
ity of hospitalized influenza cases during different periods.
The age-specific CFR was the percentage of fatal cases
among the number of hospitalized influenza cases in a
particular age group. Data analysis was performed with
SPSS software (version 21.0; IBM Corporation, Somers,
NY, USA). Two-tailed P-values that were less than 0.05
were considered to be statistically significant.
Results
According to the time distribution of influenza-related
hospitalization, five epidemics were defined during the
study period between 2009 and 2012 (Fig. 1). Among the
periods, the numbers of hospitalized cases were 19,470
(p1), 12,576 (s1), 10,013 (p2), 19,646 (s2), and 9,482 (s3).
The s2 seasonal period was the period with the largest
epidemic.
Age-specific hospitalization rates among the five periods
To investigate the age-specific hospitalization burden
among the five periods, the hospitalization rates were fur-
ther stratified by age. Compared with other age groups, the
group of children younger than 7 years of age had the high-
est hospitalization rate in both the pandemic and seasonal
periods; the hospitalization rate during s2 was markedly
higher for patients younger than 7 years of age and between
50 and 64 years of age (Fig. 2). The hospitalization rate dur-
ing p1 was the highest among the 7-12-, 13-18- and 19-49-
year-old age groups. Moreover, for the over-50 age groups,
the hospitalization rates during the seasonal periods (s1, s2
and s3) were higher than they were during the pandemics.
RR of age-specific hospitalization
To compare the RR of age-specific hospitalization be-
tween different periods, we used the age-specific
hospitalization rates during p1 as the reference (Fig. 3).
In the under-7 age group, the risk of influenza-related
hospitalization was significantly lower during p2, s1 and
s3 (RR = 0.77, 0.76 and 0.61, respectively), whereas dur-
ing s2, the under-7 age group had a higher risk of
hospitalization (RR = 1.36, 95 % CI = 1.32-1.41). Among
the 7-12-, 13-18- and 19-49-year-old groups, periods p2,
s1, s2 and s3 were associated with a lower risk of
hospitalization (RR range = 0.18-0.85), whereas there was
much lower risk during p2, s1 and s3 in the 7-12- and
13-18-year-old groups. In the over-50 age groups, the
hospitalization risk during the three seasonal periods
and p2 was consistently higher than it was during p1
(Fig. 3), except in patients over 65 years of age during p2
(RR = 1.08, 95 % CI 0.97-1.20).
Comparison of age-specific clinical severity among the
five periods
The clinical severity observed during the five periods
was assessed on the basis of the ICU admission rate and
CFR. The ICU admission and CFR were stratified by
age, and then a higher ICU admission rate and an age-
specific CFR occurred in the older age groups (50–64
and 65 years and older) (Table 1). Among the three groups
of people over 19 years of age, the ICU admission rate and
age-specific CFR during the pandemic periods were higher
than they were during the seasonal periods, and they were
higher in p2 than in p1 (Table 1).
Fig. 1 Number of influenza-related hospitalizations during the study period between 2009 and 2012 in Taiwan. Five epidemic periods were defined
according to the laboratory-confirmed influenza-positive rate from the Taiwan CDC surveillance network, and the dominant isolated viruses were
A(H1N1)pdm09 (p1), influenza B and subsequent A(H3N2) (s1), A(H1N1)pdm09 (p2), influenza B (s2) and A(H3N2) (s3) [7–9]
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Discussion
This nationwide population-based study compared the
age-specific hospitalization rates between seasonal influ-
enza periods from 2009 to 2012 and the hospitalization
rate during the (H1N1) 2009 pandemic in Taiwan.
Among the five periods, the largest number of patients was
admitted during seasonal period s2; the younger than
7 years of age group had the highest hospitalization rate
during both the pandemic and seasonal periods. For p1,
individuals younger than 50 years of age had a higher rate
of influenza-related hospitalization when compared
with other periods. Compared with the age-specific
hospitalization rate during p1, the 50–64-year-old
group had a significantly higher risk of hospitalization
during p2 as well as a higher ICU admission rate and
CFR. Moreover, there was a significantly higher risk of
hospitalization during the seasonal periods for individ-
uals over 50 years of age. By contrast, this age group
Fig. 2 Age-specific hospitalization rate during the five periods. The periods p1 and p2 were pandemic periods, whereas s1, s2 and s3 were
seasonal periods
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Fig. 3 Relative risk (RR) comparison between p1 and the remaining four epidemic periods. Age-specific RRs and 95 % CIs were estimated by
Poisson regression
Table 1 The ICU admission rate and CFR categorized by age in the five epidemics from July 2009 to October 2012
≤6 7-12 13-18 19-49 50-64 ≥65
Epidemics ICU % CFR ICU % CFR ICU % CFR ICU % CFR ICU % CFR ICU % CFR
p1 1.49 0.04 0.8 0.03 1.21 0.00 2.73 0.43 9.88 1.23 10.34 4.50
p2 1.7 0.10 1.85 0.16 1.69 0.15 4.87 0.56 13.77 3.73 13.17 5.90
s1 1.26 0.03 0.5 0.00 0.84 0.00 1.53 0.22 4.76 1.04 6.57 2.55
s2 0.74 0.06 0.4 0.09 1.4 0.17 1.84 0.17 4.33 1.25 9.78 3.13
s3 1.3 0.06 0.64 0.18 0 0.00 2.19 0.29 3.18 0.31 8.85 2.63
ICU: intensive care unit
CFR: case fatality ratio
Periods p1 and p2 were pandemic periods
Periods s1, s2 and s3 were seasonal periods
The ICU admission rate was calculated by taking the number of ICU cases divided by the number of hospitalized cases
The CFR was calculated by taking the number of fatal cases divided by the number of hospitalized cases
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had a higher ICU admission rate and CFR during the
pandemics compared with the seasonal periods.
In our study, s2 had the largest epidemic between
2009 and 2012 and led to more hospitalized patients
than the pandemics (Fig. 1). This time period corre-
sponded to the influenza season that was dominated by
influenza B in 2011–2012 [9]. During this time, Yam88-
lineage influenza B was the only one to emerge in
Taiwan, whereas Vic87-lineage influenza B and influ-
enza A (H3N2) were dominant in other regions of the
world [9, 19]. The timing and intensity of the influenza
B epidemic may be related to the size of the susceptible
population combined with the incidence of vaccine
mismatch. The (H1N1) 2009 pandemic limited the ac-
tivity of influenza B such that its prevalence was low in
2009 and 2010. This limited activity likely led to an in-
crease in the size of the population that was suscep-
tible to influenza B [9]. Furthermore, between 2009
and 2012, the influenza vaccine that only contained the
Victoria lineage of influenza B was recommended by
the World Health Organization for use in Taiwan [9].
This finding shows that effective vaccine strategies and
the continued observation of virus activity are import-
ant for minimizing the impact of seasonal influenza.
Pandemic period p1 was associated with a high
hospitalization rate for individuals younger than 50 years
of age (Fig. 2), which is consistent with the results in
Hong Kong [13], Australia and the USA [12]. Addition-
ally, when compared with the rate of age-specific
hospitalization during p1, a significantly higher risk of
hospitalization during p2 occurred for individuals from
50 to 64 years of age, whereas a much lower risk of
hospitalization during p2 was observed in the 7-12- and
13-18-year-old age groups (Fig. 3). Among those age
groups, children may have been protected during p2 by
the immunity they acquired during p1 because children
made up the major hospitalization groups during that
period (Fig. 2). Moreover, the one-dose coverage rate of
the A(H1N1)pdm09 monovalent vaccine reached 72 %
in children aged 7–18 years from November 2009 to
March 2010, which provided further immune protection
in this age group during p2 [7, 8]. Additionally, the
government-funded vaccination program was not
expanded to individuals aged 19–64 years; the older
subset of this age group (50–64 years) may have had a
higher frequency of influenza-related hospitalization
because of their higher rate of underlying medical con-
ditions compared with younger individuals [20]. These
factors could explain the difference in the rate of age-
specific hospitalization between p1 and p2.
In comparison with the pandemic period, the seasonal
periods displayed a higher hospitalization rate and risk
for individuals aged 50 years and older (Figs. 2 and 3).
For the (H1N1) 2009 pandemic, the relatively lower risk
of hospitalization among individuals born prior to 1957
(~52-91 years of age in 2009) has been explained by their
preexisting immunity because of their first exposure to in-
fluenza A (H1) during childhood [14, 21]. According to a
study in Hong Kong, a higher hospitalization rate for sea-
sonal influenza occurred in adults aged 65 years and older
when compared with that rate for the (H1N1) 2009
pandemic [13]. Our results further demonstrated that
middle-aged adults (50–64 years) in Taiwan also experi-
enced higher hospitalization rates during the seasonal pe-
riods than during the (H1N1) 2009 pandemic. Among the
three seasonal periods in our study, the rates of influenza-
related hospitalizations in adults aged 50–64 years ranged
from 21 to 44 per 100,000 patients, which are similar to
values reported in Australia (33.3 per 100,000) [22] and
the United States (37.9 per 100,000) [23]. A comparison of
influenza-related hospitalization between countries showed
that the hospitalization rates of adults aged 50–64 years
were similar but hospitalization rates in adults aged 65 and
older varied between countries, with rates of 157.4, 205 and
63 per 100,000 reported in Australia [22], the United States
[23] and Switzerland [24], respectively. The reason for this
discrepancy is not clear. Many factors may contribute to
the difference, such as population demographics, vaccin-
ation coverage, and the time period considered [22].
The ICU admission rates during the pandemic in differ-
ent countries were variable (9.1–31.0 %) and were always
calculated for the overall population [11, 20, 25]. A study
based on the 51 Canadian Nosocomial Infection Surveil-
lance Program hospitals revealed that the ICU admission
rate was significantly higher during the pandemic period
[11]. Although a previous study demonstrated that age is
significantly associated with a higher risk of ICU admis-
sion [25], our result demonstrated that the ICU admission
rate for individuals over 19 years of age was higher during
the pandemic than during the seasonal periods (Table 1).
Additionally, the age-specific CFR in individuals over
19 years of age was notably higher in p2 than in p1
(Table 1), which is comparable with the increased severity
of the second wave of the (H1N1) 2009 pandemic in Hong
Kong and Wales, UK [5, 26]. The higher age-specific CFR
in individuals over 50 years of age occurred during the
pandemics (Table 1), although this finding was different
from the high proportion of deaths in individuals under
60 years of age that occurred during the (H1N1) 2009
pandemic [14, 15]. Reports from Germany and Austria
also showed that the highest CFR during the pandemic oc-
curred in individuals aged 65 years and older [25, 27],
which is similar to what happened during the seasonal pe-
riods [28]. Therefore, the fatalities among different age
groups and in different countries were inconsistent during
the 2009 pandemic periods.
The retrieval of data from the Taiwan NHIRD was a
limitation of the present study because of a lack of
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confirmatory laboratory testing to identify cases. How-
ever, we used the specific ICD-9-CM code 487 that was
denoted in the principle discharge diagnosis codes to
identify episodes of influenza-related hospitalization.
The epidemic periods of influenza-related hospitalization
from 2009 to 2012 were comparable with data based on
the laboratory confirmation of the Taiwan CDC surveil-
lance network [7–9]. The inclusion of additional influ-
enza seasons would be helpful. Unfortunately, only
pneumonia and influenza records for 2009–2012 were
available in the dataset purchased by our hospital from
NHIRD. We hope to expand this analysis using data
from other influenza seasons in the future.
Conclusions
During both the pandemic and seasonal periods, the high-
est hospitalization rate was observed in children younger
than 7 years of age. Adults over 50 years of age had a
higher hospitalization risk during the seasonal periods and
a higher clinical severity during the pandemic periods.
These results suggest the importance of implementing in-
fluenza vaccination programs for children younger than
7 years of age and for individuals over 50 years of age dur-
ing both seasonal and pandemic periods.
Abbreviations
CDC: centers for disease control; CFR: case fatality ratio; ICD-9-
CM: International Classification of Diseases, Ninth Revision, Clinical
Modification; ICU: intensive care unit; NHIRD: Taiwan National Health
Insurance Research Database.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SMS drafted the manuscript and participated in literature searches, the
design of the study, and the revision of the manuscript. CFT, HYY were
involved in the design of the study, data analysis and the interpretation of
the results. HWP and SCCC contributed to the interpretation of the results
and the revision of the manuscript. All authors critically reviewed drafts and




The authors thank Dr. How-Ran Guo for his valuable opinion on analysis and
writing this manuscript.
Financial support
This study was funded by the grant (MOHW103-CDC-C-114-000103)
supported by Centers for Disease Control, R.O.C.(Taiwan).
Author details
1Department of Medical Research, Ditmanson Medical Foundation Chia-Yi
Christian Hospital, Chiayi City, Taiwan. 2Department of Geriatrics, Ditmanson
Medical Foundation Chia-Yi Christian Hospital, Chiayi City, Taiwan.
3Department of Pediatrics, School of Medicine, Taipei Medical University,
Taipei, Taiwan.
Received: 2 October 2015 Accepted: 16 February 2016
References
1. Cox NJ, Subbarao K. Global epidemiology of influenza: past and present.
Annu Rev Med. 2000;51:407–21.
2. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley
PM, Weintraub E, et al. The annual impact of seasonal influenza in the US:
measuring disease burden and costs. Vaccine. 2007;25:5086–96.
3. Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift.
Vaccine. 2007;25:6852–62.
4. Iskander J, Strikas RA, Gensheimer KF, Cox NJ, Redd SC. Pandemic influenza
planning, United States, 1978–2008. Emerg Infect Dis. 2013;19:879–85.
5. Keramarou M, Cottrell S, Evans MR, Moore C, Stiff RE, Elliott C, et al. Two waves
of pandemic influenza A(H1N1) 2009 in Wales–the possible impact of media
coverage on consultation rates, April-December 2009. Euro Surveill. 2011;16.
6. Truelove SA, Chitnis AS, Heffernan RT, Karon AE, Haupt TE, Davis JP.
Comparison of patients hospitalized with pandemic 2009 influenza A
(H1N1) virus infection during the first two pandemic waves in Wisconsin.
J Infect Dis. 2011;203:828–37.
7. Yang JR, Huang YP, Chang FY, Hsu LC, Lin YC, Su CH, et al. New variants
and age shift to high fatality groups contribute to severe successive waves
in the 2009 influenza pandemic in Taiwan. PLoS ONE. 2011;6:e28288.
8. Chuang JH, Huang AS, Huang WT, Liu MT, Chou JH, Chang FY, et al.
Nationwide surveillance of influenza during the pandemic (2009–10) and
post-pandemic (2010–11) periods in Taiwan. PLoS ONE. 2012;7:e36120.
9. Yang JR, Huang YP, Chang FY, Hsu LC, Lin YC, Huang HY, et al. Phylogenetic
and evolutionary history of influenza B viruses, which caused a large
epidemic in 2011–2012, Taiwan. PLoS ONE. 2012;7:e47179.
10. To KK, Wong SS, Li IW, Hung IF, Tse H, Woo PC, et al. Concurrent comparison
of epidemiology, clinical presentation and outcome between adult patients
suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal
influenza A virus infection. Postgrad Med J. 2010;86:515–21.
11. Mitchell R, Taylor G, McGeer A, Frenette C, Suh KN, Wong A, et al.
Understanding the burden of influenza infection among adults in Canadian
hospitals: a comparison of the 2009–2010 pandemic season with the
prepandemic and postpandemic seasons. Am J Infect Control. 2013;41:1032–7.
12. Karageorgopoulos DE, Vouloumanou EK, Korbila IP, Kapaskelis A, Falagas ME.
Age distribution of cases of 2009 (H1N1) pandemic influenza in comparison
with seasonal influenza. PLoS ONE. 2011;6:e21690.
13. Yang L, Wang XL, Chan KP, Cao PH, Lau HY, Peiris JS, et al. Hospitalisation
associated with the 2009 H1N1 pandemic and seasonal influenza in Hong
Kong, 2005 to 2010. Euro Surveill. 2012;17:45.
14. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C,
Hernandez M, et al. Severe respiratory disease concurrent with the
circulation of H1N1 influenza. N Engl J Med. 2009;361:674–9.
15. Lemaitre M, Carrat F. Comparative age distribution of influenza morbidity
and mortality during seasonal influenza epidemics and the 2009 H1N1
pandemic. BMC Infect Dis. 2010;10:162.
16. Simonsen L, Spreeuwenberg P, Lustig R, Taylor RJ, Fleming DM, Kroneman
M, et al. Global mortality estimates for the 2009 Influenza Pandemic from
the GLaMOR project: a modeling study. PLoS Med. 2013;10:e1001558.
17. Shiley KT, Nadolski G, Mickus T, Fishman NO, Lautenbach E. Differences in
the epidemiological characteristics and clinical outcomes of pandemic
(H1N1) 2009 influenza, compared with seasonal influenza. Infect Control
Hosp Epidemiol. 2010;31:676–82.
18. Chen Y-C, Yeh H-Y, Wu J-C, Haschler I, Chen T-J, Wetter T. Taiwan's National
Health Insurance Research Database: administrative health care database as
study object in bibliometrics. Scientometrics. 2010;86:365–80.
19. World Health Organiation. Recommended composition of influenza virus
vaccines for use in the 2012–2013 northern hemisphere influenza season. Wkly
Epidemiol Rec. 2012;87:83–95.
20. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors
associated with death or hospitalization due to pandemic 2009 influenza
A(H1N1) infection in California. JAMA. 2009;302:1896–902.
21. Miller M, Viboud C, Simonsen L, Olson DR, Russell C. Mortality and morbidity
burden associated with A/H1N1pdm influenza virus: Who is likely to be
infected, experience clinical symptoms, or die from the H1N1pdm 2009
pandemic virus ? PLoS Curr. 2009;1:RRN1013.
22. Newall AT, Wood JG, Macintyre CR. Influenza-related hospitalisation and
death in Australians aged 50 years and older. Vaccine. 2008;26:2135–41.
23. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ,
et al. Influenza-associated hospitalizations in the United States. JAMA.
2004;292:1333–40.
Sheu et al. BMC Infectious Diseases  (2016) 16:88 Page 7 of 8
24. Scuffham PA. Estimating influenza-related hospital admissions in older
people from GP consultation data. Vaccine. 2004;22:2853–62.
25. Poeppl W, Hell M, Herkner H, Stoiser B, Fritsche G, Schurz-Bamieh N, et al.
Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in
Austria. Infection. 2011;39:341–52.
26. Wu P, Goldstein E, Ho LM, Wu JT, Tsang T, Leung GM, et al. Excess mortality
impact of two epidemics of pandemic influenza A(H1N1pdm09) virus in
Hong Kong. Influenza Other Respir Viruses. 2014;8:1–7.
27. Wilking H, Buda S, von der Lippe E, Altmann D, Krause G, Eckmanns T, et al.
Mortality of 2009 pandemic influenza A(H1N1) in Germany. Euro Surveill.
2010;15.
28. Centers for Disease C, Prevention. Estimates of deaths associated with
seasonal influenza — United States, 1976–2007. MMWR Morb Mortal Wkly
Rep. 2010;59:1057–62.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Sheu et al. BMC Infectious Diseases  (2016) 16:88 Page 8 of 8
